NCT01383031

Brief Summary

The purpose of this study is to scientifically evaluate the safety, efficacy and cosmetic results of transumbilical laparoendoscopic single site cholecystectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2010

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2011

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 28, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

July 7, 2011

Status Verified

October 1, 2010

Enrollment Period

2.2 years

First QC Date

June 17, 2011

Last Update Submit

July 6, 2011

Conditions

Keywords

laparoscopic cholecystectomysingle siterandomized controlled trail

Outcome Measures

Primary Outcomes (1)

  • the incidence of surgical complications

    The primary outcome messures are the incidence of surgical complications caused by the two surgeries.Bleeding,bile duct injury and bile leakage during operation.Wound infection,umbilical hernia,poke holes hernia and biliary fistula after operation.

    up to 12 weeks

Secondary Outcomes (7)

  • transfer rate

    participants will be followed for the duration of hospital stay, an expected average of 5 days

  • quality of life scores

    up to 12 weeks

  • pain scores

    up to 12 weeks

  • length of hospital stay

    participants will be followed for the duration of hospital stay, an expected average of 5 days

  • total cost of hospitalization

    participants will be followed for the duration of hospital stay, an expected average of 5 days

  • +2 more secondary outcomes

Study Arms (2)

Laparoscopic Cholecystectomy

ACTIVE COMPARATOR

Laparoscopic cholecystectomy(4 ports or 3 ports)will be performed in a routine fashion by one full time faculty member with fellowship training in laparoscopy.

Procedure: CLC

TU-LESSC

ACTIVE COMPARATOR

TU-LESSC will be performed in a routine fashion which is same to CLC(conventional laparoscopic cholecystetomy)by one full time faculty member with fellowship training in laparoscopy through the conventional laparoscopic instruments.

Procedure: TU-LESSC

Interventions

CLCPROCEDURE

CLC(4 ports or 3 ports)will be performed in a routine fashion by one full time faculty member with fellowship training in laparoscopy.

Also known as: conventional laparoscopic cholecystectomy
Laparoscopic Cholecystectomy
TU-LESSCPROCEDURE

TU-LESSC will be performed in a routine fashion which is same to CLC by one full time faculty member with fellowship training in laparoscopy through the conventional laparoscopic instruments.

Also known as: Transumbilical laparoendoscopic single site cholecystectomy
TU-LESSC

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Years to 5 Years
  • Benign gallbladder diseases
  • KPS ≥ 70
  • informed consent

You may not qualify if:

  • Obstructive jaundice
  • Broadening of the common bile duct
  • Gallstone pancreatitis
  • Serious heart,brain,lung, metabolic diseases history
  • History of upper abdominal surgery
  • Pregnancy or breast-feeding women
  • Refuse TU-LESSC
  • BMI(Body Mass Index)≥ 30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bejing Friendship Hospital

Beijing, Bejing, 100050, China

RECRUITING

MeSH Terms

Conditions

Gallstones

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Zhongtao Zhang, doctor

    Beijing Friendship Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 17, 2011

First Posted

June 28, 2011

Study Start

October 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

July 7, 2011

Record last verified: 2010-10

Locations